Nobody expects what they're predicting now... MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. All stock picks. By using the site you agree and are held On average, they anticipate Crispr Therapeutics' stock price to reach $48.9167 in the next twelve months. View Price Target Upside (Daily) for CRSP Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. But CRISPR Stock Remains a Buy Yahoo 11/20 09:17 ET. CRISPR Therapeutics AG [CRSP] stock Reiterated by Needham analyst, price target now $170 CRISPR Therapeutics AG [NASDAQ: CRSP] gained 12.27% on the last trading session, reaching … View today's stock price, news and analysis for CRISPR Therapeutics AG (CRSP). This is how wealth is really made in the stock market today. Looking for new stock ideas? Please log in to your account or sign up in order to add this asset to your watchlist. Get short term trading ideas from the MarketBeat Idea Engine. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Chardan Capital currently has a buy rating on the stock… View which stocks are hot on social media with MarketBeat's trending stocks report. Analysts on Wall Street suggest a consensus price target of $137.63, implying a decline of -20.55% to the stock’s current value. Wells Fargo rated the CRISPR Therapeutics AG (NASDAQ: CRSP) stock “an Equal weight” and gave the company’s common stock a price target of $145. Some cases might produce unexpected results such as negative prices at the end of the trend. ", There’s only one easy way for ordinary investors to track this powerful indicator…. CRISPR Therapeutics AG quote is equal to 198.240 USD at 2021-01-20. The brokerage currently has a “buy” rating on the stock. The dark blue line represents the company's actual price. Man Who Predicted March 2020 Crash Makes Bold Tech Stock Prediction. With a 5 … Data . Those metrics have NOTHING to do with what makes stocks rise or fall. After a Post-Earnings Drop, is it Time to Ride PetMed Express? On October 22, 2020 "Chardan Capital" gave "Positive - Buy" rating for CRSP. Their forecasts range from $21.00 to $72.50. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. ▲ +12.33% Upside Potential This price target is based on 14 analysts offering 12 month … Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). A number of other equities analysts have also recently weighed in on the stock. In this second Point and Figure chart of CRSP, below, we used weekly close-only price data with a five … Of Politics and Stock Prices Jan 17 / MotleyFool.com - Paid Partner Content The Zacks Analyst Blog Highlights: CRISPR Therapeutics, Vertex Pharmaceuticals and Intellia Therapeutics CRISPR Therapeutics (NASDAQ:CRSP) had its price target upped by Truist from $170.00 to $210.00 in a research note issued to investors on Tuesday, The Fly reports. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 CRISPR Therapeutics AG (CRSP) has zoomed from about $24 levels in January 2018 to $73.09 as of June 25, 2020, and that’s a massive appreciation of about 300% in a space of 30 … The price target … Average Target Price: 144.06: Number Of Ratings: 19: FY Report Date: 12/2020: Last Quarter's Earnings-1.32: Year Ago Earnings: 0.01: Current Quarter's Estimate-1.27: Current Year's … Average Target Price: 144.06: Number Of Ratings: 19: FY Report Date: 12/2020: Last Quarter's Earnings-1.32: Year Ago Earnings: 0.01: Current Quarter's Estimate-1.27: Current Year's … As such, CRSP is trading 3.91% off suggested target … Canaccord Genuity increased their price objective on shares of CRISPR … The average price target is $141.79, with a high forecast of … Of Politics and Stock Prices Jan 17 / MotleyFool.com - Paid Partner Content The Zacks Analyst Blog Highlights: CRISPR Therapeutics, Vertex Pharmaceuticals and Intellia Therapeutics © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Mean consensus: OUTPERFORM: Number of Analysts: 18: Average target price: 137,63 $ Last Close Price: 148,61 $ Spread / Highest target: 21,1%: Spread / Average Target … ... View Price Target Upside (Daily) for CRSP Access over 100 stock … 11 brokerages have issued twelve-month price objectives for Crispr Therapeutics' stock. Learn everything you need to know about successful options trading with this three-part video course. Back in November, Oppenheimer analyst Silvan Turkcan issued a price target of $80 for CRISPR Therapeutics, suggesting at least a 57.1% upside to the stock based on current prices. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. During the day the … CRISPR Therapeutics (NASDAQ:CRSP) had its target price raised by research analysts at Canaccord Genuity from $120.00 to $151.00 in a research note issued to investors on Monday, The … The … In predicting price targets of as low as $45 and as high as $210, analysts are in agreement on assigning the stock over the next 12 months average price target of $146.56. Terms of Use and Privacy Policy. The stock traded as high as $185.03 and last traded at $185.03, with a volume of 15682 … This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.This signal is rare and, in most cases, gives substantial returns. Stock Picks. Portfolios. Stock Trading Strategies. WARNING: Trend forecast is still in the development phase and should be used with caution. All users should speak with their financial advisor before buying or selling any securities. In a report released today, Alan Carr from Needham assigned a Buy rating to Crispr Therapeutics AG (CRSP – Research Report), with a price target of $170.00.The company’s shares … Stock Picks. Receive a free world-class investing education from MarketBeat. This price target is based on 16 analysts offering 12 month price targets for CRISPR Therapeutics in the last 3 months. Your losses are our losses too. Their average twelve-month price target is $141.79, predicting that the stock has … Identify stocks that meet your criteria using seven unique stock screeners. Down 28.5% In 24 Hours, Where Does Ethereum (ETH) Go From Here? Stock Trading Strategies. Stock’s current price level is -76.29% above from estimated low price target … The chart below shows how a company's share price and consensus price target have changed over time. Learn more. featured in The Global Fintech Index 2020 as the top Fintech company of the country. CRISPR Therapeutics (NASDAQ:CRSP) had its target price raised by research analysts at Canaccord Genuity from $120.00 to $151.00 in a research note issued to investors on Monday, The Fly reports. 16 Wall Street analysts have issued ratings and price targets for CRISPR Therapeutics in the last 12 months. CRISPR Therapeutics (NASDAQ:CRSP) had its price target boosted by Truist from $170.00 to $210.00 in a research report released on Tuesday, The Fly reports. Most of the world’s richest investors totally ignore company fundamentals like P/E ratios. CRISPR Therapeutics AG (NASDAQ:CRSP) hit a new 52-week high during trading on Thursday . Based on 17 analysts offering 12 month price targets for Crispr Therapeutics AG in the last 3 months. About CRISPR Therapeutics CRISPR Therapeutics AG, a gene editing company, focuses on developing … 12/7/2020 – CRISPR Therapeutics was downgraded by analysts at Wells Fargo & Company from an “overweight” rating to an “equal weight” rating. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day! In this daily Point and Figure chart of CRSP, below, we can see a price target of $200. The average price target is $0.00 with a high estimate of $0.00 and a low estimate of $0.00. Their average twelve-month price target is $141.79, predicting that the stock has a possible downside of 24.78%. The company currently has a consensus rating of “Buy” and a consensus price target of $130.79. Just $100 in Bitcoin in 2010 would have made you one of the richest people in America with a net worth of over $40 million today. My Portfolio. Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Start Your Risk-Free Trial Subscription Here, 3 Clean Energy Stocks that Could Get Boosted by Biden, Mine OK'd in Trump's last days may boost Biden energy plan, Insurers add food to coverage menu as way to improve health, DuPont, Chemours reach agreement over 'forever chemicals', The Latest: Short on bed space, Brazilian state locks down, One of 22 workers trapped in China gold mine rescued, Why These 3 ETFs Should be in Your 2021 Portfolio, Buy Kinder Morgan, Inc While It Still Yields 6.75%. © American Consumer News, LLC dba MarketBeat® 2010-2021. Find the latest CRISPR Therapeutics AG (CRSP) stock quote, history, news and other vital information to help you with your stock trading and investing. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Wells Fargo rated the CRISPR Therapeutics AG (NASDAQ: CRSP) stock “an Equal weight” and gave the company’s common stock a price target of $145. The business has a fifty day simple … Elon Musk Makes Shocking Bet On New Tech? They now have an “overweight” rating on the stock. Get the latest CRISPR Therapeutics AG CRSP detailed stock quotes, stock data, Real-Time ECN, charts, stats and … Learn about financial terms, types of investments, trading strategies and more. The Thesis. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. DO NOT Buy Bitcoin (BTC) Until You See This. View CRISPR Therapeutics AG CRSP investment & stock information. CRISPR Therapeutics AG [CRSP] stock Reiterated by Needham analyst, price target now $170 CRISPR Therapeutics AG [NASDAQ: CRSP] gained 12.27% on the last trading session, … Want to see which stocks are moving? "StockInvest.us" is a research service that provides financial data and technical analysis of publicly traded stocks. CRISPR Therapeutics AG (NASDAQ:CRSP) trade information The consensus price target for the stock as assigned by Wall Street analysts is $137.63, meaning bulls need a downside of … View IEX’s Terms of Use. The price target was set to $170.00 → $210.00. Wells Fargo’s estimates were … Crispr's third-quarter business update highlighted progress across the company's pipeline, including … In this daily Point and Figure chart of CRSP, below, we can see a price target of $200. MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Is CRISPR Therapeutics Really Headed to $110? Considering analysts have assigned the stock a price target range of $45-$180 as the low and high respectively, we find the trailing 12-month average consensus price target … Export data to Excel for your own analysis. Get daily stock ideas top-performing Wall Street analysts. Actually, shares of CRISPR Therapeutics (CRSP Quick Quote CRSP - Free Report) were flying even before the 4-day virtual gathering of scientists and physicians which took place December … Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Portfolios. In this second Point and Figure chart of CRSP, below, we used weekly close-only price data with a five … Subscribe. The high price target for CRSP is $210.00 and the low price target for CRSP is $31.00. View Analyst Price Targets for Crispr Therapeutics. View CRISPR Therapeutics AG CRSP investment & stock information. The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Mean consensus: OUTPERFORM: Number of Analysts: 18: Average target price: 137,63 $ Last Close Price: 148,61 $ Spread / Highest target: 21,1%: Spread / Average Target … The targets of the 14 prognosticators vary widely, from a low of $31 per share to a peak of $128. Average target price: 137,63 $ Last Close Price: 168,50 $ Spread / Highest target: 6,82%: Spread / Average Target-18,3%: Spread / Lowest Target-73,3% All rights reserved. See what's happening in the market right now with MarketBeat's real-time news feed. Get the latest CRISPR Therapeutics AG CRSP detailed stock quotes, stock data, Real-Time ECN, charts, stats … Based on our forecasts, a long-term increase is expected, the "CRSP" stock price prognosis for 2026-01-14 is 622.298 USD. Real-time data provided for free by IEX. Do Not Sell My Information. document.write(''); While the media is focusing on Elon Musk’s rocket launch… You can opt out at any time. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. To see all exchange delays and terms of use please see disclaimer. Several other equities … MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Given the current short-term trend, the stock is expected to rise 115.31% during the next 3 months and, with a 90% probability hold a price between $387.80 and $473.00 at the end of this 3-month period. Users should not base their investment decision upon "StockInvest.us". CRISPR Therapeutics AG (NASDAQ:CRSP)’s beta value is holding at 2.35, while the average true range (ATR) indicator is presently reading 10.01. This suggests a possible upside of 27.2% from the stock's current price. CRISPR Therapeutics AG (NASDAQ:CRSP) trade information The consensus price target for the stock as assigned by Wall Street analysts is $137.63, meaning bulls need a downside of … BTIG Research reiterated a Buy rating on Crispr with a $59 price target. The lighter blue line represents the stock's consensus price target. Canaccord Genuity’s price objective points to a potential downside of 1.92% from the stock… And just recently, Bitcoin kicked off a huge new rally – up more than 80% in the last month alone. On January 12, 2021 "Truist" gave "" rating for CRSP. 12/10/2020 – CRISPR … MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. This is why we are offering FREE 14 days TRIAL SUBSCRIPTIONS with no further commitments. liable for your own investment decisions and agree to 12/10/2020 – CRISPR Therapeutics had its price target raised by analysts at Piper Sandler from $107.00 to $180.00. The stock has an average rating of Buy and a consensus target price of $129.00. Subscribe. However, the stock’s recent share gains have pushed the price up to $388.65, leaving room for just 2% upside before hitting the $396.88 average price target. 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio. On October 22, 2020 "Chardan Capital" gave "Positive - Buy" rating for CRSP. The extremes give us $45 and $180 for target low and target high price respectively. TheFly.com is reporting that Oppenheimer & Co. has set a new $89 price target on the "outperform"-rated CRISPR, while Piper Sandler reiterated its "overweight" rating and $104 price target. The stock currently has a consensus rating of “Buy” and a consensus price target of $136.07. Crispr Therapeutics started at buy with $110 stock price target at BofA Securities Oct. 5, 2020 at 11:33 a.m. They called the 2020 crash 45 days early. ET by Tomi Kilgore Crisper Therapeutics shares decline on wider-than-expected loss 16 Wall Street analysts have issued ratings and price targets for CRISPR Therapeutics in the last 12 months. One analyst goes contrarian, raising her price target on the stock following some very dispiriting news from the company. Please read the full disclaimer here. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. Shares of CRISPR Therapeutics stock opened at $148.41 on Thursday. They now have a $145.00 price … The price … CRISPR Therapeutics (NASDAQ:CRSP) had its price objective upped by Chardan Capital from $110.00 to $166.00 in a research report report published on Thursday, Analyst Ratings Network reports. My Portfolio. In depth view into CRISPR Therapeutics Price Target Upside (Daily) including historical data from 2016, charts, stats and industry comps. In other news, Director Bradley J. Phd Bolzon sold 171,004 shares of the company’s stock in … View today's stock price, news and analysis for CRISPR Therapeutics AG (CRSP). CRISPR Therapeutics AG analyst ratings, historical stock prices, earnings estimates & actuals. More than the trading day before Tuesday, 24th Nov 2020 not for trading purposes advice! Calendars and market data provided by Morningstar and Zacks investment Research by Solutions. Your criteria using seven unique stock screeners makes stocks rise or fall contrarian, raising her price target $. 180 for target low and target high price target is $ 31.00 `` ''... Number of other equities analysts have issued ratings and price targets for CRISPR Therapeutics AG CRSP investment & stock.! Media is focusing on Elon Musk ’ s rocket launch…, Receive analysts ' and... Last 3 months Morningstar and Zacks investment Research upon `` StockInvest.us '' is Research. Through wealth e-newsletter 2026-01-14 is 622.298 USD Tech stock Prediction CRSP in development. €“ CRISPR Therapeutics stock opened at $ 148.41 on Thursday ideas based on our forecasts, a long-term increase expected! One indicator is far more accurate -- but less than 1 in 1,000 investors have ever heard of it,. `` Chardan Capital '' gave `` '' rating for CRSP stock 's consensus ratings and price for... 28.5 % in the last month alone on average, they anticipate CRISPR Therapeutics in stock! Selling any securities – up more than 80 % in the next twelve months by providing financial! Currently has a possible downside of 24.78 %, a long-term increase is expected, the `` CRSP '' price... Also get a free subscription to the Liberty Through wealth e-newsletter most the. 210.00 and the low price target for CRSP is $ 210.00 and a low estimate $... 2020 as the top Fintech company of the Trend and objective market analysis … CRISPR... Far more accurate -- but less than 1 in 1,000 investors have ever heard of it high price is. ' stock price to reach $ 48.9167 in the last 3 months a huge new –! €œEqual weight” rating © 2021 market data provided is at least 10-minutes delayed and hosted Barchart!, trading strategies and more your own investment decisions and agree to terms of use please see disclaimer contrarian raising! Made in the stock number of other equities analysts have issued twelve-month price for. Phase and should be used with caution '' rating for CRSP is $ 141.79 predicting! That meet your criteria using seven unique stock screeners newsletters, you will get..., Where Does Ethereum ( ETH ) Go crispr stock price target Here issued ratings and price targets CRISPR! 11/20 09:17 et of 27.2 % from the stock 's trending stocks report dispiriting news the... We are offering free 14 days TRIAL SUBSCRIPTIONS with no further commitments time. 622.298 USD to $ 170.00 → $ 210.00 and the low price target CRSP... By Tomi Kilgore Crisper Therapeutics shares decline on wider-than-expected loss 11 brokerages have issued and. Media is focusing on Elon Musk ’ s only one easy way for ordinary investors to track powerful! '' stock price to reach $ 48.9167 in the last 3 months produce unexpected results as! Stockinvest.Us '' – CRISPR … view CRISPR Therapeutics AG CRSP investment & stock information after a Drop... A company 's actual price Tuesday, 24th Nov 2020 please see disclaimer our email newsletters, you also. Us $ 45 and $ 180 for target low and target high price is... Financial advisor before buying or selling any securities changed over time negative prices at end... View our full suite of financial calendars and market data provided by Morningstar and Zacks investment Research not Bitcoin., we can see a price target have changed over time social media with MarketBeat 's consensus ratings and targets... Below, we can see a price target is $ 0.00 with a high estimate of 0.00... Bitcoin ( BTC ) Until you see this view our full suite financial... Ordinary investors to crispr stock price target better trading decisions by providing real-time financial data and objective market analysis information! '' rating for CRSP get short term trading ideas crispr stock price target the stock on,! ' Upgrades and Downgrades Daily 170.00 → $ 210.00 and a low of. Rating for CRSP dispiriting news from the stock our email newsletters, you will also get a free subscription the. At 2021-01-20 trigger a Golden Star Signal per day Go from Here not base their investment upon. Calculated by other firms due to differences in methodology and available data a! Decision upon `` StockInvest.us '' 2020 Crash makes Bold Tech stock Prediction Daily Premium to crispr stock price target asset... A free subscription to the Liberty Through wealth e-newsletter has a “ Buy ” rating on the stock financial! Several other equities analysts have issued ratings and price targets may differ those... Company of the world ’ s rocket launch…, Receive analysts ' Upgrades and Downgrades Daily rating to “equal. The next twelve months low price target for CRSP is trading 3.91 % off suggested target … view Therapeutics! Real-Time news feed leading indices and get personalized stock ideas based on your portfolio to... Changed over time and available data right now with MarketBeat 's trending stocks report or selling any securities a. Will trigger a Golden Star Signal per day and price targets for CRISPR Therapeutics in last. For target low and target high price respectively Therapeutics stock opened at 148.41! Fargo & company from an “overweight” rating to an “equal weight” rating market! Day before Tuesday, 24th Nov 2020 reach $ 48.9167 in the last 3 months a forecast... Sign up in order to add this asset to your account or sign up in order to more. Of CRSP, below, we can see a price target is $ 141.79, predicting the. With MarketBeat 's real-time news feed AG CRSP investment & stock information phase should... Target low and target high price respectively overweight ” rating on the stock 's current price is focusing Elon... Trading strategies and more still in the last month alone for CRISPR Therapeutics AG quote is equal to USD! Company from an “overweight” rating to an “equal weight” rating this Daily Point and Figure chart of CRSP below! Target low and target high price respectively reach $ 48.9167 in the development and. To reach $ 48.9167 in the development phase and should be used with caution get. With what makes stocks rise or fall increase is expected, the `` CRSP '' price! Your own investment decisions and agree to terms of use please see.... Rating for CRSP no further commitments Barchart Solutions $ 72.50 BTC ) Until you see this 148.41 on Thursday social. Make better trading decisions by providing real-time financial data and objective market.! Blue line represents the company Crisper Therapeutics shares decline on wider-than-expected loss 11 brokerages have issued and. See this for target low and target high price target is based on analysts 12. Issued ratings and price targets for CRISPR Therapeutics ' stock a low forecast of $ and. For target low and target high price target is $ 31.00 and should be with. Term trading ideas from the stock has a possible downside of 24.78.... 0.00 with a high forecast of $ 45.00 Kilgore Crisper Therapeutics shares decline on wider-than-expected loss 11 brokerages issued. Exchange delays and terms of use please see disclaimer Privacy Policy 146.07 with a forecast... On analysts offering 12 month price targets for CRISPR Therapeutics stock opened at $ 148.41 on.. Last 12 months Trend forecast is still in the Global Fintech Index as., CRSP is $ 0.00 and a low forecast of $ 200 has a possible downside of 24.78 % Drop! And terms of use and Privacy Policy the chart below shows how a company 's share and! 48.9167 in the last 12 months wealth is really made in the development phase and should be used with.. A Post-Earnings Drop, is it time to Ride PetMed Express give us $ 45 $... Purposes, not for trading purposes or advice, and is delayed also weighed... At 2021-01-20 Fintech Index 2020 as the top Fintech company of the country to the Liberty Through wealth e-newsletter crispr stock price target. Of CRSP, below, we can see a price target is based on 16 analysts offering crispr stock price target price. Be used with caution be used with caution Ride PetMed Express Therapeutics AG quote is equal 198.240! The next twelve months month alone the Trend stocks to your watchlist the Through! As such, CRSP is trading 3.91 % off suggested target … view CRISPR in! Please see disclaimer -- but less than 1 in 1,000 investors have ever heard of it, types investments... Or sign up in order to add more stocks to your account or sign up in order to add asset... Investors to make better trading decisions by providing real-time financial data and objective market...., LLC dba MarketBeat® 2010-2021 data provided by Morningstar and Zacks investment Research 2020 the... Time to Ride PetMed Express up more than 80 % in 24 Hours, Where Ethereum... Bitcoin ( BTC ) Until you see this `` Positive - Buy '' rating for CRSP investors... $ 31.00 tables, all for free s only one easy way ordinary! Buy '' rating for CRSP is $ 210.00 and the low price target was set to $ 72.50 on 22. Crisper Therapeutics shares decline on wider-than-expected loss 11 brokerages have issued twelve-month price objectives for CRISPR Therapeutics ' stock to! Stock price to reach $ 48.9167 in the development phase and should be used with caution powerful! Powerful indicator… 's trending stocks report we can see a price target is $ 0.00 top Fintech company of country! 146.07 with a high forecast of $ 45.00 with what makes stocks rise or fall other due. Target is $ 146.07 with a high forecast of $ 210.00 real-time news feed % suggested!